Western Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,590
Closed -$203K – 979
2026
Q2
$203K Sell
2,590
-955
-27% -$65.1K 0.01% 965
2026
Q1
$229K Buy
+3,545
New +$250K 0.01% 879

Other funds holding HALO

Western Wealth Management's HALO Position: Q3 2026 in Review

Western Wealth Management sold out of Halozyme (HALO) in Q3 2026, closing a stake of 2,590 shares — an estimated $203K sold.

Western Wealth Management first reported a position in HALO in Q1 2026 and held it in 2 quarters. The position peaked at $229K in Q1 2026. 774 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Western Wealth Management reported no remaining Halozyme position as of Q3 2026 after selling out during the quarter.
  • Western Wealth Management sold 2,590 Halozyme shares in Q3 2026, an estimated $203K.
  • Western Wealth Management first reported a position in Halozyme in Q1 2026 and held it in 2 quarters.
  • Western Wealth Management's Halozyme position peaked at $229K in Q1 2026.
  • 774 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Western Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.